Higher 5-year survival of Certolizumab Pegol in young women with axial spondyloarthritis. BIOBADASER data
14/08/2023
M. Moreno1 , C. Sánchez-Piedra2 , V. Jovani3 , R. Cáliz Cáliz4 , Y. PerezVera5 , V. Emperiale6 , F. Sanchez-Alonso2 , M. Pombo7 , M. Llop Vilaltella1 , J. Calvet1 on behalf of BIOBADASER project working group.
EULAR 2022
DOI: 10.1136/annrheumdis-2022-eular.1130
https://ard.bmj.com/content/81/Suppl_1/769.1